Spots Global Cancer Trial Database for Evaluation of Drug Activity in Women With Breast Cancer and no Previous Herceptin Treatment
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Evaluation of Drug Activity in Women With Breast Cancer and no Previous Herceptin Treatment
Official Title: A Randomised Double-Blind Placebo-controlled Multicentre Phase I Study to Assess the Biological Activity of AZD8931 in Patients With Early Breast Cancer Who Are Ineligible for Treatment With Trastuzumab as Defined by IHC Status
Study ID: NCT01596530
Conditions
Study Description
Brief Summary: To compare the activity of AZD8931 against placebo on the cell markers in cancer tumours
Detailed Description: A Randomised Double-Blind Placebo-controlled Multicentre Phase I Study to Assess the Biological Activity of AZD8931 in Patients with Early Breast Cancer who are Ineligible for Treatment with trastuzumab as defined by IHC status
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Research Site, Dusseldorf, , Germany
Research Site, Essen, , Germany
Research Site, Wittenberg, , Germany
Research Site, Seoul, , Korea, Republic of
Research Site, Yonsei, , Korea, Republic of
Research Site, Taichung, , Taiwan
Research Site, Taipei, , Taiwan
Contact Details
Name: Serban Ghiorghiu, M.D.
Affiliation: Internal
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
